New camera could slash skin cancer surgery time
NCT ID NCT07482956
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a special camera (LC-OCT) can help surgeons remove basal cell carcinoma more efficiently. About 290 adults with skin cancer will be randomly assigned to standard surgery or surgery guided by this imaging tool. The goal is to see if the camera reduces the number of surgical rounds needed to remove all cancer cells.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Line-field confocal optical coherence tomography (LC-OCT) imaging
What this could lead to
If successful, this imaging technique could make skin cancer surgery faster and more precise, reducing the need for multiple surgeries and preserving more healthy tissue.
What could go wrong
This is an early-stage study with 290 participants, so results may not apply to all patients. The imaging tool may not always clearly show tumor edges, and it adds extra time before surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ludwig Maximilian University Hospital
Munich, Germany
Contact
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
-
München Klinik
Munich, Germany
Contact
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
-
University Hospital Augsburg
Augsburg, Germany
Contact
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
-
University Hospital Dresden
Dresden, Germany
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
-
University Hospital Erlangen
Erlangen, Germany
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact